TrialPharmacotherapy2025

A Multicenter, Open-Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial.

Kathleen A Stringer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.